Federal Budgetary Institution of Science "North-West Public Health Research Center"

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.	Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease	Recruiting	Phase 1	2026-06-12		NCT07645534
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.	Deglutition Disorders, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, bile duct disorder, biliary dyskinesia, biliary tract disorder, cholelithiasis, colonic disorder, common bile duct disorder, digestive system disorder, dyskinesia of esophagus, esophageal disorder, functional colonic disease, gastroesophageal reflux disease, intestinal disorder, irritable bowel syndrome, postcholecystectomy syndrome	Recruiting	Phase 1	2026-02-19		NCT07421011

Clinical trials